Safety of a Cyclooxygenase-2 Inhibitor in Patients With Aspirin-Sensitive Asthma

Chest - United States
doi 10.1378/chest.121.6.1812
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy of Reslizumab in Asthma Patients With Aspirin Sensitivity and Elevated Blood Eosinophils

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Novel Strategy for Cystitis Glandularis: Oral Treatment With Cyclooxygenase-2 Inhibitor

International Journal of Urology
Urology
2016English

Aspirin-Triggered Lipoxin in Patients Treated With Aspirin and selectivevs.nonselective COX-2 Inhibitors

British Journal of Clinical Pharmacology
Pharmacology
2010English

Selective Cyclooxygenase-2 Inhibitor Use and Progression of Renal Function in Patients With Chronic Kidney Disease: A Single-Center Retrospective Cohort Study

International Journal of Nephrology and Renovascular Disease
Nephrology
2016English

Safety of Bronchial Thermoplasty in High Risk Patients With Severe Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Protocatechualdehyde Synergizes With Aspirin at the Platelet Cyclooxygenase-1 Level

Planta Medica
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2011English

Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases
Rheumatology
2016English

Aspirin-Induced Asthma and Aspirin-Induced Polyps

Practica Otologica, Supplement
Otorhinolaryngology
1991English

Membranous Nephropathy Associated With the Relatively Selective Cyclooxygenase-2 Inhibitor, Etodolac, in a Patient With Early Rheumatoid Arthritis

Internal Medicine
Internal MedicineMedicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy